1. Home
  2. MSPR vs ITRM Comparison

MSPR vs ITRM Comparison

Compare MSPR & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSPR
  • ITRM
  • Stock Information
  • Founded
  • MSPR 2014
  • ITRM 2015
  • Country
  • MSPR United States
  • ITRM Ireland
  • Employees
  • MSPR N/A
  • ITRM N/A
  • Industry
  • MSPR
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSPR
  • ITRM Health Care
  • Exchange
  • MSPR NYSE
  • ITRM Nasdaq
  • Market Cap
  • MSPR 7.8M
  • ITRM 40.0M
  • IPO Year
  • MSPR N/A
  • ITRM 2018
  • Fundamental
  • Price
  • MSPR $1.00
  • ITRM $0.96
  • Analyst Decision
  • MSPR
  • ITRM Strong Buy
  • Analyst Count
  • MSPR 0
  • ITRM 2
  • Target Price
  • MSPR N/A
  • ITRM $7.00
  • AVG Volume (30 Days)
  • MSPR 552.1K
  • ITRM 532.9K
  • Earning Date
  • MSPR 08-13-2025
  • ITRM 08-13-2025
  • Dividend Yield
  • MSPR N/A
  • ITRM N/A
  • EPS Growth
  • MSPR N/A
  • ITRM N/A
  • EPS
  • MSPR N/A
  • ITRM N/A
  • Revenue
  • MSPR $13,085,000.00
  • ITRM N/A
  • Revenue This Year
  • MSPR N/A
  • ITRM N/A
  • Revenue Next Year
  • MSPR N/A
  • ITRM $270.19
  • P/E Ratio
  • MSPR N/A
  • ITRM N/A
  • Revenue Growth
  • MSPR 34.74
  • ITRM N/A
  • 52 Week Low
  • MSPR $0.98
  • ITRM $0.81
  • 52 Week High
  • MSPR $13.50
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • MSPR N/A
  • ITRM 44.42
  • Support Level
  • MSPR N/A
  • ITRM $0.93
  • Resistance Level
  • MSPR N/A
  • ITRM $1.03
  • Average True Range (ATR)
  • MSPR 0.00
  • ITRM 0.04
  • MACD
  • MSPR 0.00
  • ITRM -0.00
  • Stochastic Oscillator
  • MSPR 0.00
  • ITRM 26.15

About MSPR MSP RECOVERY INC

MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: